Orange Health Labs is preparing to enter the radiology segment as it expands beyond its core pathology business and taps into the growing demand for specialised and preventive healthcare testing. The move will enable the diagnostics company to broaden its service portfolio while addressing the increasing demand for comprehensive diagnostic solutions.
India’s Diagnostics Market Continues to Grow
Meanwhile, India’s diagnostics industry is witnessing strong growth, supported by rising health awareness, preventive healthcare and increasing adoption of advanced diagnostic technologies. According to ICRA, the organised diagnostics segment is estimated to have grown by more than 15% in FY26. This growth is encouraging diagnostic companies to expand their capabilities and offer a wider range of specialised tests and healthcare services.
Orange Health Plans Wider Diagnostic Portfolio
Orange Health Labs currently focuses primarily on pathology testing. However, the company now plans to strengthen its specialised testing portfolio and expand its overall test menu. In addition, Orange Health intends to enter adjacent diagnostic categories, including radiology, as part of its broader expansion strategy. The company expects this category expansion to take place over the next few quarters. Dhruv Gupta, Co-founder of Orange Health Labs, highlighted the company’s plans to expand into new diagnostic segments as it builds a broader healthcare testing platform.
Focus on Specialised and Preventive Healthcare
By combining its existing pathology capabilities with specialised testing and radiology, Orange Health Labs aims to address the evolving needs of patients seeking faster, more comprehensive and preventive diagnostic services. As reported by thehindubusinessline.com, the expansion reflects a broader shift in India’s diagnostics industry, with organised players increasingly moving beyond traditional pathology to provide integrated and technology-enabled healthcare diagnostics.